Free press releases distribution network?

Agency / Source: Sartorius Stedim Biotech S.A.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Sartorius Stedim Biotech and Bosch Packaging Technology Announce Global Collaboration - Sartorius Stedim Biotech (SSB) and Bosch Packaging Technology (Bosch) announced a long-term global partnership agreement - Sartorius-Stedim.com
Sartorius Stedim Biotech and Bosch Packaging Technology Announce Global Collaboration

 

PRZOOM - /newswire/ - Goettingen, Crailsheim, Germany, 2012/06/20 - Sartorius Stedim Biotech (SSB) and Bosch Packaging Technology (Bosch) announced a long-term global partnership agreement - Sartorius-Stedim.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sartorius Stedim Biotech (SSB), a leading international pharma and biotech supplier, and Bosch Packaging Technology (Bosch), one of the leading providers of process technology and packaging solutions for the pharmaceutical industry, today announced a long-term global partnership agreement. The agreement covers the mutual design and development of single-use filling solutions to be used on Bosch’s aseptic filling equipment for final fill-and-finish operations of drug products. SSB will provide Bosch with pre-configured single-use filling transfer sets, consisting of bags, filters, tubing and connectors. Bosch will combine them with its aseptic filling and barrier isolation technology into new, innovative systems for aseptic filling, and exclusively market, distribute and service these new filling systems under its own brand name.

With the new product line PreVAS (Pre-Validated, Pre-Assembled, Pre-Sterilized), Bosch will supply its customers with highly cost effective, plug and play tools for aseptic filling operations that provide additional flexibility and come along with comprehensive validation packages. PreVAS will be launched at Achema 2012.

Joachim Brenner, responsible for Bosch’s Pharma Liquid portfolio worldwide and Site Manager of the plant Crailsheim, stated: “By integrating SSB’s single-use technologies into our aseptic filling systems, we are expanding our product and service portfolio in the area of fill-and-finish unit operations by an important component. With our joint expertise, we intend to develop configurable and customized single-use filling solutions and to provide strong validation and technical support.”

Jean-Marc Cappia, Vice President of Marketing, Fluid Management Technologies, at SSB stated: “The partnership with Bosch promotes the implementation of single-use technologies into critical applications such as final filling operations and strengthens the confidence into single-use technology. Our customers from the pharmaceutical and biopharmaceutical industry are facing mounting cost pressure and time constraints. By integrating single-use technology into fill-and-finish unit operations, they can handle smaller batches and product change overs in a safe, economic and flexible way.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Sartorius Stedim Biotech S.A.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sartorius Stedim Biotech and Bosch Packaging Technology Announce Global Collaboration

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Sartorius Stedim Biotech |
Contact: Press Office - Sartorius-Stedim.com 
+33(4)4 42 84 56 00 press[.]sartorius-stedim.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sartorius Stedim Biotech S.A. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Sartorius Stedim Biotech S.A. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  1Click Games

Visit  JobsWare.com

Visit  BizJobs.com







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today